FDA
-
-
-
-
-
-
-
Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update
-
-
-
-
-
-
-
Aadi Bioscience (AADI) Announces Publication of Long-Term Efficacy and Safety Data Supporting FYARRO
-
-
-
-
-
-
-
Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update
-
-
-
-
-
-
-
Aadi Bioscience (AADI) Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
-
-
-
-
-
-
-
Aadi Bioscience to Participate in Upcoming Investor Events
-
-
-
-
-
-
-
Aadi Bioscience (AADI) Appoints Mohammad Hirmand to its Board
-
-
-
-
-
-
-
Aadi Bioscience to Present at the 43rd Annual Cowen Healthcare Conference
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

